Office of Research & Development |
|
Project Number: | I01CX002060-01A2 |
Title: | Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients |
Principal Investigator: | David Canaday |
Location: | Cleveland, OH |
Congressional District Code: | 11 |
Research Service: | Clinical Science R&D |
Project Period: | July 2021 - June 2024 |
FY 2024 Funding Amount: | $260,075 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |